FHM LIFE Sciences Viii, LLC is 10% Owner at Arcutis Biotherapeutics, Inc. (ARQT). They have made 1 open-market trade across 1 company since 2023, most recently 2023-10-24.
CIK 0001698823
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $200K since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARQT | 8,764,232 | $252.8M |
Shares reported on the most recent Form 4, priced at the 2023-10-26 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARQT | BUY | 2023-10-24 | 2023-10-26 | $2.50 | $200K | -2.1% | -18.3% | +90.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.